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The aim of this paper was to prepare a self-microemulsifying docetaxel (Dtx) using PLGA, Tetraglycol, Labrasol, and Cremophor
ELP.ThepreparedDtx-loadedself-microemulsifyingsystem(SMES)showedtheinitialsizeoftherangeof80–100nmwithnarrow
size distribution and the negative zeta-potential values. Its morphology was a spherical shape by atomic force microscopy. In
experiment of stability, Dtx-loaded SMES prepared in DW and BSA condition showed good stability at 37
◦Cf o r7d a y s .T h e
viability of the B16F10 cells incubated with Dtx-loaded SMES, Dtx-solution, and Taxol were decreased as a function of incubation
time. In conclusion, we conﬁrmed that Dtx-loaded SMES showed an inhibitory eﬀect for proliferation of B16F10 melanoma cells.
1.Introduction
The ﬁrst-line treatment of various cancers includes surgery,
radiotherapy, or a combined treatment regimen [1–4]. As
second-line treatment for cancer, the chemotherapy using
anticancer drugs may be treated to remove completely
cancers [1–6]. Many highly potent anticancer drugs are
clinically treated as available commercial products. However,
the utility of these cancer chemotherapeutic drugs in clinical
applications is limited by very low solubility in aqueous
[7, 8].
Paclitaxel (Ptx), isolated from the bark of Taxus brevifo-
lia, has signiﬁcant activity against a variety of tumors such
as breast cancer, advanced ovarian carcinoma, lung cancer,
and head and neck carcinoma [9]. Docetaxel (Dtx) is also an
anticancer drug belonging to the second generation of the
taxoid family [10]. Ptx and Dtx are hydrophobic drugs with
pooraqueoussolubility[11,12].ToenhancesolubilityofPtx,
it is currently formulated for clinical application as Taxol by
Cremophor EL-based solvent system containing dehydrated
ethanol [13].
Recently, various formulations such as liposomes, emul-
sions, micelles, microspheres, and polymeric nanoparticles
have been employed for the encapsulating Ptx and Dtx
including several anticancer drugs [14–20]. The selection of
aproperPtxandDtxencapsulatingformulationisimportant
to improve the instability problems such as subsequent
precipitation of the solubilised hydrophobic Ptx and Dtx for
in vivo treatment.
The poor water solubility of Ptx and Dtx can be
improved by the formulation with oil, low molecular
weight surfactants, and so forth. The self-microemulsifying
system (SMES) are isotropic mixtures of oil, a surfactant,
and cosurfactants, which form ﬁne oil-in-water emulsions
when exposed to aqueous media [21–23]. Thus, the SMES
was found to be highly suitable for the incorporation of
hydrophobicPtxandDtx.BecauseSMESmaybeapromising
way to load hydrophobic Dtx in delivery system, here, we
report on the preparation of Dtx-loaded SMES which could
result in an improvement of stability of the solubilised
hydrophobic Dtx in aqueous media.
2.MaterialsandMethods
2.1.Materials. Poly(d,l-lactide-co-glycolide)(PLGA,molec-
ular weight, 8,000, 20,000 and 90,000g/mole) was purchased
from Boerhinger Ingelheim (Ingelheim, Germany). Doc-
etaxel was purchased from Naprod Life Science Pvt, Ltd
(India). Paclitaxel (Genexol) was purchased from Samyang2 Journal of Nanomaterials
Table 1: Formulation for the preparation of Dtx-loaded SMES.
Composition Formulation
( g , w / w ) F 1F 2F 3
Drug 0.003
(Docetaxel)
Solubilizer 0.5
(Tetraglycol)
PLGA 8k g/mol 0.005
PLGA 20k g/mol 0.005
PLGA 90k g/mol 0.005
Cosurfactant 0.14
(Labrasol)
Surfactant 0.16
(Cremophor ELP)
Zeta-potential (mV) −7.7 ±0.4 −2.8 ±1.3 −4.3 ±0.6
Genex Co. (Seoul, Korea). Caprylocaproyl macrogol-8 glyc-
eride (Labrasol) was obtained from Gattefosse (Westwood,
NJ, USA). Cremophor ELP was purchased from BASF
(Germany). Tetraglycol was purchased from Sigma Chemical
Co.(St.Louis,MO,USA).Allotherchemicalswereofreagent
grade. The deionized water (DW) was prepared by a Milli-Q
puriﬁcation system from Millipore (Molsheim, France).
2.2. Preparation of Dtx-Loaded SMES, Dtx-Solution, and
Taxol. As e r i e so fS M E Sw a sp r e p a r e di ne a c ho ft h ev a r i o u s
formulas with PLGA, docetaxel, solubilizer, surfactant, and
cosurfactant. Brieﬂy, PLGA, Dtx, Tetraglycol, Labrasol, and
Cremophor ELP in the various ratios (Table 1)w e r ea d d e d
into the vial, followed by heating on a hot plate to 60–70◦C
with stirring and vortex mixing until Dtx had perfectly dis-
solved. A solution of 3mg of SMES was carefully weighed in
10mLtube.Itwasthenemulsiﬁedbycontactingto7mLDW
and vortexed, followed by keeping at room temperature for
about 30 minutes to use in subsequent studies. The prepared
Dtx-loaded SMES used without any puriﬁcation. A 6mg of
DtxandPtxwasaddedinto10mLmixtureofCremophorEL
and ethanol (v/v = 1/1) to prepare Dtx-solution and Taxol,
respectively [19–21].
2.3. Dtx Encapsulation Eﬃciency. The Dtx-loaded SMES and
Dtx-solution prepared as ﬁnal concentration of 0.43mg/mL
of Dtx in 7mLDW. The ﬂask was allowed to equilibrate
for 30 minutes at RT. The solution was thereafter ﬁltered
through a ﬁlter paper. The Dtx encapsulation eﬃciency in
the solution was analyzed using a high-performance liquid
chromatography (HPLC), Agilent 1200 series LC system
equippedwithdetectionat220nmusingadiodearraydetec-
tor (Agilent Technologies, Inc., Santa Clara, USA). A Sunﬁre
C18 column (4.6 × 150mm, 5μm )w a su s e d .T h em o b i l e
phase consisted of a distilled water:acetonitrile:methanol
(41:48:11 v/v) mixture, and the column was eluted at a
ﬂow rate of 1.0mL/min. The Dtx encapsulation eﬃciency
was calculated by comparison with the standard calibration
curves prepared with known concentrations of Dtx. Three
independent Dtx-loaded SMES experiments were performed
for each Dtx encapsulation eﬃciency and then averaged.
2.4. Size Analysis of Dtx-Loaded SMES, Dtx-Solution and
Taxol. For analysis, formulation (50μL) of Dtx-loaded
SMES, Dtx-solution and Taxol were diluted with 50mLDW
in volumetric ﬂask, followed by vortex mixing gently mixed.
The particle size, size distribution, and surface charge of
resultant formulation were determined by dynamic light
scattering (DLS, ELS-8000, Photal, Japan) at room tem-
perature. The analysis was individually measured for three
samples of Dtx-loaded SMES, Dtx-solution, and Taxol, and
then calculated as average value using three individual sizes.
2.5.MorphologyofDtx-LoadedSMES. Theshapeandsurface
morphology were investigated by atomic force microscopy
(AFM). A 10μL of Dtx-loaded SMES was transferred onto
silicon wafer which was washed with MeOH. The wafer was
quickly placed in liquid nitrogen, followed by the freeze-
drying for 2 days. AFM measurements were carried out in
the tapping mode with a nanoscope IV instrument (Digital
Instruments Inc.).
2.6. Stability of Dtx-Loaded SMES, Dtx-Solution, and Taxol.
Dtx-loaded SMES, Dtx-solution, and Taxol were prepared
with 7mL DW or a solution of 0.9%NaCl and 5% bovine
serum albumin (Bovogen, Australia) and individually placed
in 10mL tube. The tube was constantly shaken at 100rpm
and 37◦C for 7 days. At the set time, the droplet size
was individually measured for three samples of Dtx-loaded
SMES, Dtx-solution, and Taxol, and then calculated as
average value.
2.7.CellCulture. B16F10melanomacelllinewasobtainedby
Korea Cell Line Bank and cultured in culture media (MEM
(Minimum Essential Medium, Gibco BRL, USA) supple-
mented with 10% fetal bovine serum (Gibco BRL, USA)
and 1% PS (Penicillin streptomycin, Gibco BRL, USA)), and
maintained at 37◦Ci n5 %C O 2 humidiﬁed atmosphere. The
cells were seeded into 75-cm2 ﬂasks, cultured, and changed
medium every 2 days.
2.8. Cell Cytotoxicity Tests. B16F10 cell suspension (2 ×
104 cells/well) was seeded in a 48-well plate. The cells were
incubated overnight to allow for cell attachment under cul-
ture media. The cells were incubated without and with Dtx-
loaded SMES, Dtx-solution, and Taxol for 7 days without
changing of culture media [19–21] .T h eﬁ n a lc o n c e n t r a t i o n
of the Dtx and Ptx in the cell culture medium was adjusted
to 1μg/mL. Cell viability was determined by using water-
soluble enzyme substrate MTT which was converted to
purplewater-insolubleproductformazanaccumulatedinthe
cytoplasmofviablecells.Cellviabilityofeachwellperformed
individually and then calculated as average value. In brief,
100μL of PBS solution of the MTT tetrazolium substrate
(5mg/mL) was added after 1, 4, and 7 days. After incubation
f o r4hat37 ◦C, the resulting purple formazanprecipitate was
solubilized by the addition of 1mL of DMSO and shakenJournal of Nanomaterials 3
F1-0 F2-0 F3-0
(a) 0 day in DW
F1-7 F2-7 F3-7
(b) 7 day in DW
F1-0 F2-0 F3-0
(c) 0 day in BSA
F1-7 F2-7 F3-7
(d) 7 day in BSA
Figure 1: Pictures (a, c) before and (b, d) after incubation at 37◦C for 7 days of Dtx-loaded SMES prepared in (a, b) DW and (c, d) BSA with
diﬀerent formulations F1–F3.
for 30minutes. An aliquot from each well (100μL) was
transferred to 96-well plates and then read using a plate
reader of an ELISA (E-max, Molecular Device, USA). The
optical density of each well was determined at 590nm.
2.9. Statistical Analysis. Cytotoxicity data were obtained
from independent experiments in which each of the ﬁve
treatment conditions were tested in triplicate. All data are
presented as means ± standard deviations (SD). The results
were analyzed by one-way ANOVAs using the Prism 3.0
software package (GraphPad Software Inc., San Diego, CA,
USA).
3. Results andDiscussion
3.1.PreparationofDtx-LoadedSMES. TheDtx-loadedSMES
were prepared by using Dtx, tetraglycol, Cremophor ELP,
Labrasol, and PLGA; the formulation is summarized in
Table 1. The prepared Dtx-loaded SMES were observed
visually. As shown in Figure 1(a) Dtx-loaded SMES (F1–F3)
showed the transparent emulsion solution for all formula-
tions, indicating that Dtx was successfully incorporated into
the SMES. The Dtx encapsulation eﬃciency is above 70%.
Dtx-solution and Taxol showed the transparent solution.
The size and size distribution of Dtx-loaded SMES
measured by DLS were shown in Table 2. The average size
dtx-90k.002
x 1μm/div
z 50nm/div
1
2
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Figure 2: AFM image of Dtx-loaded SMES (F3).4 Journal of Nanomaterials
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Figure 3:DLSimagesmeasuredafterincubationat37◦Cat0,4,and7daysofDtx-loadedSMESpreparedinBSAwithdiﬀerentformulations
F1–F3 (0, 4 and 7 represent the incubation time).
of the Dtx-loaded SMES determined from the DLS was
in the range of 80–100nm. It seemed that the changes of
PLGA molecular weight did not signiﬁcantly aﬀect the size
of the resultant Dtx-loaded SMES. Even though the droplet
size distribution was slightly broader for increasing PLGA
molecular weight, F1–F3 is formulation with appropriate
size. Meanwhile, Dtx-solution and Taxol showed the average
size in the range of 200–300nm.
The AFM morphology of Dtx-loaded SMES showed the
spherical shape with smooth surface as shown in Figure 2.A
comparatively uniform droplet size of Dtx-loaded SMES was
also observed at AFM, indicating no aggregation or adhesion
among SMES.
3.2. Stability of Dtx-Loaded SMES. The stability of Dtx-
loaded SMES is important to maintain the in vivo therapeu-
ticconcentrationofDtx.Surfacechargemaybeanimportant
indication for the stability of Dtx-loaded SMES in medium.
The zeta potential of the Dtx-loaded SMES indicates the
negative surface charges (Table 1). This implies that the
repulsion among the Dtx-loaded SMES with the same type
of surface charge can provide stability.
To examine stability of the solubilised Dtx in DW and
BSA condition, Dtx-loaded SMES, Dtx-solution, and Taxol
were prepared with DW or a solution of 0.9% NaCl and 5%
BSA (Figures 1 and 4). The prepared Dtx-loaded SMES, Dtx-
solution, and Taxol were constantly shaken at 100rpm andJournal of Nanomaterials 5
Table 2: The changes of average particle size by incubation for 0–7 days at 37◦C of Dtx-loaded SMES prepared in DW and BSA condition
with diﬀerent formulations F1–F3.
Condition In DW In BSA conditiona
Formulation F1 F2 F3 F1 F2 F3
Particle size (nm)
b
Initial 85 ±19 2 ±39 3 ±13 116 ±48 7 ±2 113 ±8
4d a y s 9 3±58 8 ±47 7 ±20 218 ±15 93 ±6 167 ±11
7 days 115 ±59 9 ±49 3 ±15 234 ±3 126 ±9 226 ±3
aA solution of 0.9% NaCl and 5% bovine serum albumin.
bThe mean and standard deviation of particle size for each formulation was calculated by individual measurement of three formulations.
Dtx-solution-0 Taxol-0
(a) 0 day in DW
Dtx-solution-7 Taxol-7
(b) 7 day in DW
Dtx-solution-0 Taxol-0
(c) 0 day in BSA
Dtx-solution-7 Taxol-7
(d) 7 day in BSA
Figure 4: Pictures (a, c) before and (b, d) after incubation at 37◦C
for 7 days of Dtx-solution and Taxol prepared in (a, b) DW and (c,
d) BSA.
37◦C for 7 days. There is a little change of particle size for
F1–F3, Dtx-solution, and Taxol prepared in DW as shown in
Figures 1(b) and 1(d), indicating the stability of Dtx-loaded
SMES, Dtx-solution, and Taxol in DW.
For Dtx-loaded SMES, Dtx-solution, and Taxol prepared
in BSA, the size of Dtx-loaded SMES steadily increased as
af u n c t i o no ft i m e( Table 2). The sizes of F1 and F3 at 7
days were approximately two times larger than those at 0 day.
Meanwhile, F2 was maintained the original size for at least 4
days and only increased from 87 to 126nm (Figure 3). It can
be noted that proper Dtx encapsulating formulation can lead
to stability of solubilised Dtx. Meanwhile Dtx-solution and
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Figure 5: In vitro cytotoxicity of B16F10 melanoma cell against
Dtx-loaded SMES of formulations F1, F2, and F3 for 1, 4, and 7
days. The cells grown on a culture plate without Dtx-loaded SMES
were used as the control and the cells with Taxol and Dtx-solution
were used for comparison (∗P<. 001).
Taxol precipitated immediately in BSA condition, indicating
nonstability of Dtx-solution and Taxol (Figure 4).
3.3. Antitumor Activity of Dtx-Loaded SMES. The cytotoxi-
city for Dtx-loaded SMES (F1–F3), Dtx-solution, and Taxol
for comparison was evaluated using B16F10 melanoma cell
line (Figure 5). The B16F10 cells in the control experiment
proliferated as a function of culture time. However, the
viability of the B16F10 cells incubated with Dtx-loaded
SMES (F1–F3) was approximately 50%–60% and 30%–
40% at 4 days and 7 days, indicating that increasing the
incubation time from 24 to 48h led to more cell death.
A similar viability of the B16F10 cells was observed when
Dtx-solution and Taxol were used for 4 days. However, the
viability of the B16F10 cells for Dtx-solution and Taxol was
maintained when the incubation time was extended to 7
days.ThisindicatesthattheDtx-loadedSMESwassomewhat
more eﬀective in inhibition of B16F10 cell proliferation than
Dtx-solution and Taxol. Thus, it appeared that the slightly6 Journal of Nanomaterials
improved inhibition of B16F10 cell proliferation may be due
to the Dtx-loaded SMES’s stability.
4. Conclusion
The authors prepared the Dtx-loaded SMES to improve their
stability. The prepared Dtx-loaded SMES showed a spherical
shape in the range of 80–90nm. The authors found that
the formulation of the Dtx-loaded SMES prepared in DW
and BSA showed a little change in the particle size for
7 days. Dtx-loaded SMES showed an inhibitory eﬀect on
B16F10 melanoma proliferation. Thus, further research on
the animal model using Dtx-loaded SMES prepared in this
work is now in progress.
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